A clearer view of peptide research | Revolutionary Peptides

From an idea to evidence.

Peptides are small chains of amino acids. Some are medicines; many are still research questions. The interesting work lies in the distance between those two states.

Five evidence stages: cells and animals, Phase I, Phase II, Phase III, and regulatory review. — A route through the evidence, not a timetable. A candidate can pause or stop at any station; approval concerns a particular product and use.

Five evidence stations, from mechanism studies to regulatory review. — A route through the evidence, not a timetable. A candidate can pause or stop at any station; approval concerns a particular product and use.

Follow the pipeline

Read the mechanisms and limits of the 19 entries carried into this October 2026 almanac.

Open the wall chart

Know the compound

Seven profiles separate molecular ideas, animal findings, human studies and regulatory context.

Browse the profiles

Read a study well

Start with study design, uncertainty and the difference between a measured signal and a useful treatment.

Explore the guides

Layered cream, teal, mustard and lilac paper forms arranged like an open science almanac — A new view of an old question: how much evidence sits behind an interesting idea?

The next question is the useful one.

The catalogue covers tissue repair, copper-binding peptides, pineal peptides and the growth hormone axis. Alongside them sit newer lines of work: mitochondrial signals, senescent cells, constrained peptide shapes and targeted delivery.

We read for the model tested, the outcome measured and the uncertainty left behind. A striking cell result does not settle a clinical question.

Find a starting paper in the research library

Two kinds of index

The pipeline concerns compounds. The Q2 2026 Innovation Leadership Index is a dated editorial assessment of suppliers. Neither turns a research listing into an approved treatment.

Read the May 2026 edition

Begin with the foundations.

What is a peptide?

Amino acids, receptors and why shape and delivery matter.

Read the primer

What does a dose study show?

Why a published amount belongs to its study, rather than a personal protocol.

Read the evidence guide

What does safety mean?

Identity, purity, contamination, interactions and the gaps in long-term follow-up.

Read about safety